Paul E. Drawz

4.6k total citations
98 papers, 2.5k citations indexed

About

Paul E. Drawz is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Surgery. According to data from OpenAlex, Paul E. Drawz has authored 98 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Cardiology and Cardiovascular Medicine, 37 papers in Nephrology and 17 papers in Surgery. Recurrent topics in Paul E. Drawz's work include Blood Pressure and Hypertension Studies (50 papers), Chronic Kidney Disease and Diabetes (23 papers) and Dialysis and Renal Disease Management (16 papers). Paul E. Drawz is often cited by papers focused on Blood Pressure and Hypertension Studies (50 papers), Chronic Kidney Disease and Diabetes (23 papers) and Dialysis and Renal Disease Management (16 papers). Paul E. Drawz collaborates with scholars based in United States, Italy and France. Paul E. Drawz's co-authors include Mahboob Rahman, Mahboob U. Rahman, Scott Reule, Denise C. Babineau, Robert N. Foley, Daniel P. Murphy, Brook Watts, George Thomas, Joachim H. Ix and Laura Barisoni and has published in prestigious journals such as Circulation, Blood and Annals of Internal Medicine.

In The Last Decade

Paul E. Drawz

96 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul E. Drawz United States 27 1.0k 903 291 283 276 98 2.5k
Marie Evans Sweden 35 1.1k 1.1× 1.5k 1.6× 277 1.0× 273 1.0× 337 1.2× 147 3.4k
John J. Sim United States 31 981 1.0× 1.4k 1.5× 483 1.7× 214 0.8× 474 1.7× 117 3.4k
Samuel Fatoba United Kingdom 10 513 0.5× 1.4k 1.6× 289 1.0× 345 1.2× 275 1.0× 21 2.8k
Laurie A. Tomlinson United Kingdom 30 861 0.8× 1.2k 1.3× 360 1.2× 243 0.9× 351 1.3× 115 2.9k
Eric L. Knight United States 23 1.2k 1.2× 1.5k 1.7× 398 1.4× 313 1.1× 243 0.9× 31 4.0k
Amanda H. Anderson United States 33 1.2k 1.1× 1.5k 1.7× 448 1.5× 330 1.2× 492 1.8× 99 3.4k
Amy Earley United States 20 648 0.6× 566 0.6× 430 1.5× 238 0.8× 352 1.3× 41 2.3k
Nisha I. Parikh United States 32 1.8k 1.7× 487 0.5× 541 1.9× 444 1.6× 448 1.6× 102 4.1k
Ho Jun Chin South Korea 36 643 0.6× 1.9k 2.1× 409 1.4× 408 1.4× 328 1.2× 188 4.0k
Graziella D’Arrigo Italy 30 653 0.6× 917 1.0× 447 1.5× 237 0.8× 232 0.8× 123 2.6k

Countries citing papers authored by Paul E. Drawz

Since Specialization
Citations

This map shows the geographic impact of Paul E. Drawz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Drawz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Drawz more than expected).

Fields of papers citing papers by Paul E. Drawz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Drawz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Drawz. The network helps show where Paul E. Drawz may publish in the future.

Co-authorship network of co-authors of Paul E. Drawz

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. Drawz. A scholar is included among the top collaborators of Paul E. Drawz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. Drawz. Paul E. Drawz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brooks, Thomas G., Jordana B. Cohen, Raymond R. Townsend, et al.. (2024). Prognostic utility of rhythmic components in 24-h ambulatory blood pressure monitoring for the risk stratification of chronic kidney disease patients with cardiovascular co-morbidity. Journal of Human Hypertension. 38(5). 420–429. 5 indexed citations
2.
Fischman, Clara, Raymond R. Townsend, Debbie L. Cohen, et al.. (2024). Pulse Pressure and Cardiovascular and Kidney Outcomes by Age in the Chronic Renal Insufficiency Cohort (CRIC). American Journal of Hypertension. 38(2). 129–138. 1 indexed citations
3.
Murphy, Daniel P., Julian Wolfson, Scott Reule, et al.. (2024). Kidney Outcomes with Sodium–Glucose Cotransporter-2 Inhibitor Initiation after AKI among Veterans with Diabetic Kidney Disease. Kidney360. 5(3). 335–343. 5 indexed citations
4.
Murphy, Daniel P., Julian Wolfson, Scott Reule, et al.. (2023). Renin–Angiotensin–Aldosterone System Blockade after AKI with or without Recovery among US Veterans with Diabetic Kidney Disease. Journal of the American Society of Nephrology. 34(10). 1721–1732. 9 indexed citations
5.
6.
Zhang, Jianqiu, Gretchen Hultman, Paul E. Drawz, et al.. (2022). Application of Causal Discovery Algorithms in Studying the Nephrotoxicity of Remdesivir Using Longitudinal Data from the EHR.. PubMed. 2022. 1227–1236. 2 indexed citations
7.
Murray, Anne M., Yelena Slinin, David E. Tupper, et al.. (2022). Kidney-Metabolic Factors Associated with Cognitive Impairment in Chronic Kidney Disease: A Pilot Study. American Journal of Nephrology. 53(6). 435–445. 6 indexed citations
8.
Whelton, Paul K., Dean S. Picone, Raj Padwal, et al.. (2022). Global proliferation and clinical consequences of non-validated automated BP devices. Journal of Human Hypertension. 37(2). 115–119. 9 indexed citations
9.
Yannopoulos, Demetris, et al.. (2021). Impact of AKI in Patients with Out-of-Hospital Cardiac Arrest Managed with VA ECMO. Kidney360. 2(11). 1827–1830. 4 indexed citations
10.
Ghazi, Lama, Kristine Yaffe, Manjula Kurella Tamura, et al.. (2020). Association of 24-Hour Ambulatory Blood Pressure Patterns with Cognitive Function and Physical Functioning in CKD. Clinical Journal of the American Society of Nephrology. 15(4). 455–464. 10 indexed citations
11.
Lakshminarayan, Kamakshi, Thomas A. Murray, Sarah M. Westberg, et al.. (2020). Mobile Health Intervention to Close the Guidelines-To-Practice Gap in Hypertension Treatment: Protocol for the mGlide Randomized Controlled Trial. JMIR Research Protocols. 10(1). e25424–e25424. 1 indexed citations
12.
Jotwani, Vasantha, Pranav S. Garimella, Ronit Katz, et al.. (2020). Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants. American Journal of Nephrology. 51(10). 797–805. 22 indexed citations
13.
Bruggeman, Leslie A., Zhenzhen Wu, Liping Luo, et al.. (2019). APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy. PLoS ONE. 14(10). e0224408–e0224408. 21 indexed citations
14.
Reule, Scott, et al.. (2015). Dual Renin-Angiotensin-Aldosterone System Inhibition for the Treatment of Diabetic Kidney Disease: Adverse Effects and Unfulfilled Promise. Current Diabetes Reports. 15(10). 70–70. 3 indexed citations
15.
Moon, Helen, Yang Liu, R. Tyler Miller, et al.. (2015). A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial. BMC Nephrology. 16(1). 56–56. 56 indexed citations
16.
Murray, Anne M., Elizabeth J. Bell, David E. Tupper, et al.. (2015). The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function. American Journal of Kidney Diseases. 67(4). 593–600. 42 indexed citations
17.
Drawz, Paul E. & Mark E. Rosenberg. (2013). Slowing progression of chronic kidney disease. Kidney International Supplements. 3(4). 372–376. 40 indexed citations
18.
Drawz, Paul E., Mohamed Abdalla, & Mahboob Rahman. (2012). Blood Pressure Measurement: Clinic, Home, Ambulatory, and Beyond. American Journal of Kidney Diseases. 60(3). 449–462. 66 indexed citations
19.
Drawz, Paul E., Sarah Baraniuk, Barry R. Davis, et al.. (2012). Cardiovascular risk assessment: Addition of CKD and race to the Framingham equation. American Heart Journal. 164(6). 925–931.e2. 15 indexed citations
20.
Drawz, Paul E., et al.. (2009). Nocturnal dosing and chronic kidney disease progression: new insights. Current Opinion in Nephrology & Hypertension. 18(5). 381–385. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Evans Breakdown of academic impact, for papers by John J. Sim Breakdown of academic impact, for papers by Samuel Fatoba Breakdown of academic impact, for papers by Laurie A. Tomlinson Breakdown of academic impact, for papers by Eric L. Knight Breakdown of academic impact, for papers by Amanda H. Anderson Breakdown of academic impact, for papers by Amy Earley Breakdown of academic impact, for papers by Nisha I. Parikh Breakdown of academic impact, for papers by Ho Jun Chin Breakdown of academic impact, for papers by Graziella D’Arrigo
Rankless by CCL
2026